APA (7th ed.) Citation

Rosaria Vincenza Giglio BD, P., Emir M. Muzurović MD, P., Angelo Maria Patti MD, P., Peter P. Toth MD, P., Manyoo A. Agarwal MD, Wael Almahmeed MD, . . . Manfredi Rizzo MD, P. (2023). Treatment with Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors (PCSK9i): Current Evidence for Expanding the Paradigm? SAGE Publishing.

Chicago Style (17th ed.) Citation

Rosaria Vincenza Giglio BD, PhD, PhD Emir M. Muzurović MD, PhD Angelo Maria Patti MD, PhD Peter P. Toth MD, Manyoo A. Agarwal MD, Wael Almahmeed MD, PhD Aleksandra Klisic MD, PhD Marcello Ciaccio MD, and PhD Manfredi Rizzo MD. Treatment with Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors (PCSK9i): Current Evidence for Expanding the Paradigm? SAGE Publishing, 2023.

MLA (9th ed.) Citation

Rosaria Vincenza Giglio BD, PhD, et al. Treatment with Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors (PCSK9i): Current Evidence for Expanding the Paradigm? SAGE Publishing, 2023.